2023 Apr 28 Head and Neck Surgical Oncology Grand Rounds

April 28, 2023

Updates in Otology Grand Rounds


Ghedak Ansari, MD, 
Kaiser Permanente, Oakland

Caitlin Pacheco, MD
Kaiser Permanente, Oakland

Peter Debbaneh, MD
Kaiser Permanente, Oakland

Nik Block, MD
Kaiser Permanente, Oakland

Jacob Hoerter, MD
Kaiser Permanente, Oakland

Elias Saba, MD
Kaiser Permanente, Oakland

Seo Moon, MD
Kaiser Permanente, Oakland

Kevin Wang, MD
Kaiser Permanente, Oakland


Statement of Disclosure:

Kaiser Foundation Hospital Oakland/Richmond has determined that none of the speakers, planning committee members, and consultants for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients. Kaiser Foundation Hospital Oakland/Richmond does not endorse any brand name products.

Kaiser Foundation Hospital Oakland/Richmond is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians.

Kaiser Foundation Hospital Oakland/Richmond designates this live activity for a maximum of 2.0 AMA PRA Category 1 credit(s)TM.. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

Nurses may report up to a maximum of 1.0 hours of credit towards the continuing medical education requirements for license renewal by the California Board of Registered Nurses.

Target Audience

This program will be of interest to all primary care physicians. Specialist and other interested clinicians are invited to attend within their scope of practice where applicable.

Learning Objectives

As a result of this education, participants will be able to:

  1. Describe the unique laboratory work-up of patients with medullary thyroid cancer, as well as identify relevant genetic profiles associated with the disease.
  2. Understand updates in immunotherapy used for advanced cutaneous squamous cell carcinoma and be able to counsel patients on their use.
  3. Describe the unique association between nasopharyngeal carcinoma and EBV, as well as stratify patient risk based on lab values.



Additional Information

Oakland Medical Center
Conference room: 
Virtual TEAMS Meeting
Course summary
Available credit: 
  • 2.00 AMA PRA Category 1 Credit(s)™
  • 4.00 Attendance
Course opens: 
Course expires: 
Event starts: 
04/28/2023 - 8:00am PDT
Event ends: 
04/28/2023 - 1:30pm PDT
Oakland Medical Center
Oakland, CA 94611
United States

Available Credit

  • 2.00 AMA PRA Category 1 Credit(s)™
  • 4.00 Attendance
Please login or register to take this course.